Skip to search formSkip to main contentSkip to account menu

cremophor

Known as: chremofore 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

Polyethylene Glycolspolyethoxylated castor oil

Narrower (3)

cremophor RH 40cremophor WO-CE 5070macrogloglycerol hydrostearate 40

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics.
2003
2003
Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.
Review
2002
Review
2002
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study
We characterized the toxicity and determined the maximum tolerated dose of non-break weekly paclitaxel (Taxol) in chemotherapy… 
2001
2001
Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.
2000
2000
Possible Drug‐Associated Pancreatitis after Paclitaxel‐Cremophor Administration
Paclitaxel, a relatively new antineoplastic agent, is associated with numerous side effects, including two reported cases of… 
1999
1999
Inhibition of paclitaxel elimination in the isolated perfused rat liver by Cremophor EL
Purpose: Cremophor can alter the pharmacokinetics of cytotoxic drugs, including doxorubicin and etoposide. In view of its… 
Highly Cited
1996
Highly Cited
1996
Cremophor pharmacokinetics in patients receiving 3-, 6-, and 24-hour infusions of paclitaxel.
BACKGROUND Paclitaxel (Taxol) is a new drug with efficacy against a variety of malignant tumors. The clinical formulation of… 
1994
1994
Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines
Background. Paclitaxel (Taxol, Bristol‐Myers Squibb, Princeton, NJ) is a promising drug for the treatment of ovarian cancer… 
Highly Cited
1994
Highly Cited
1994
Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction.
Cyclosporin A (CsA) is widely used to suppress graft rejection following transplantation and in the treatment of a variety of… 
1982
1982
Effects of deoxycorticosterone and its ring A-reduced derivatives on the nervous system
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)